Literature DB >> 12145471

Elevated IgA and IgM anticardiolipin antibodies in acute Kawasaki disease.

Monesha Gupta1, Rosemary Johann-Liang, James B Bussel, Welton M Gersony, Thomas J A Lehman.   

Abstract

There is marked activation of the endothelium and immune system in Kawasaki disease. Anticardiolipin antibodies (aCL) can cause activation of the endothelium. We measured aCL levels in acute Kawasaki disease patients and compared them to other febrile patients to see whether their aCL responses were different. Twenty-one patients with acute Kawasaki disease and 16 patients with an acute febrile illness were recruited. The aCL levels were measured in the sera of febrile patients and in Kawasaki disease patients prior to immunoglobulin therapy. There was no significant difference between the IgG aCL levels (p = 0.87) between the Kawasaki disease and febrile patients. However, the IgM (p = 0.01) and IgA (p = 0.03) aCL were significantly higher in patients with acute Kawasaki disease than in febrile children. Elevation of IgA aCL has been reported in association with other vasculitides and IgA-secreting plasma cells have been demonstrated in the vascular tissue in Kawasaki disease. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145471     DOI: 10.1159/000063118

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  7 in total

1.  [Fever, bilateral conjunctivitis, cervical lymphadenopathy, lacquered lips and rash].

Authors:  S Cantemir; S Flüshöh; G Koch; A Laubert
Journal:  HNO       Date:  2004-04       Impact factor: 1.284

2.  Kawasaki syndrome during pregnancy: a case report and literature review.

Authors:  Eleftheria Lefkou; Ula Mahadeva; Andy Jones; Jane Hancock; Beverley J Hunt
Journal:  Obstet Med       Date:  2008-09-01

3.  Study of the autoantibody profile after the acute phase of Kawasaki disease in a cohort of children from North India.

Authors:  R Venkatraman; S Singh; R W Minz
Journal:  Rheumatol Int       Date:  2005-11-25       Impact factor: 2.631

4.  Antiphospholipid antibodies in children with Kawasaki disease: a preliminary study from north India.

Authors:  M George; J Ahluwalia; A Gupta; J Masih; S K Bose; S Singh
Journal:  Rheumatol Int       Date:  2013-05-15       Impact factor: 2.631

Review 5.  Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies.

Authors:  Laura Andreoli; Micaela Fredi; Cecilia Nalli; Silvia Piantoni; Rossella Reggia; Francesca Dall'Ara; Franco Franceschini; Angela Tincani
Journal:  Curr Rheumatol Rep       Date:  2013-07       Impact factor: 4.592

6.  Elevated Serum Levels of IL-21 in Kawasaki Disease.

Authors:  Yon Jung Bae; Mi Hyun Kim; Hae Yong Lee; Young Uh; Mee Kyung Namgoong; Byung Ho Cha; Jin-Kyong Chun
Journal:  Allergy Asthma Immunol Res       Date:  2012-06-29       Impact factor: 5.764

7.  Kawasaki disease in a girl with Turner syndrome: a remarkable association.

Authors:  Stefano Stagi; Stefania Losi; Francesco Chiarelli; Maurizio de Martino; Fernanda Falcini
Journal:  Ital J Pediatr       Date:  2014-02-28       Impact factor: 2.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.